Carestream Health Announces Distribution Agreement with DMS Group in France

Carestream HealthCarestream Health in France has signed a distribution agreement with Apelem, a subsidiary of the DMS Group in France. Under the terms of the agreement, Carestream can sell two new Platinum remote controlled radiographic tables developed by Apelem exclusively to customers in France and Belgium.

"We are extremely proud that Carestream Health, a world leader in the medical imaging field, should show interest in our new remote controlled radiographic table solution. This distribution contract is testament to the technological excellence of the Platinum table and confirms its major potential in the radiography market," said Jean-Paul Ansel, Managing Director of DMS. "Given the commercial power of Carestream Health, we believe that this agreement will represent a major component of growth for the next several years."

Distribution of the new Platinum dRF model with a fixed detector and the Platinum model with mobile detector and wireless functionality will complement the CARESTREAM DRX-1 family of highly productive capture systems for digital radiography. Founded on the wireless, cassette-size CARESTREAM DRX-1 detector, this portfolio currently includes the DRX-1 System that can convert analogue X-ray rooms to DR technology in less than one day; the DRX-Mobile Retrofit kit to upgrade mobile X-ray systems to wireless DRX-1 technology and a fully automated DRX-Evolution suite that offers virtually unlimited patient positioning.

"The agreement reached with DMS will enable us to offer a complete range of medical imaging systems to our French and Belgian customers”, said Anton Graule, European Sales & Business Development Manager, Medical Imaging Solutions, Carestream Health. "We have been particularly impressed by the technical capabilities of the Platinum radiographic table, as well as by its design and the diagnostic aids developed by DMS which make this table unique in its market."

Related news articles:

About Diagnostic Medical Systems
Specialising in high technology medical diagnostic solutions, Groupe DMS currently ranks number one in France in the development, design and manufacture of dedicated digital and conventional imagery radiology systems as well as bone mineral density testing. The Group's strategy, principally based on technological innovation, enables it to offer a complete range of medical imaging systems. Its representation on all continents, thanks to a network of 80 national distributors, subsidiaries and joint venture partners brings, for Groupe DMS, an international dimension to the quality of its products. DMS products are aimed at hospitals, clinics, radiologists and specialist medical practitioners who use diagnostic tools (rheumatoid and orthopaedic practitioners, gynaecologists etc). DMS has a listing in section C of the Euronext Paris market of NYSE Euronext - Code ISIN : FR 0000063224 - Mnemonic Code: DGM
DMS Contact: Nicolas BOUCHEZ, 0033 (0)1 77 35 04 37

About Carestream Health
Carestream Health is a world supplier of medical and dental imaging systems and medical computer solutions; molecular imaging systems for life science research and drug development; radiographic films and digital systems for the non-destructive testing market. For more information on the wide range of products, solutions and services, please contact your Carestream Health representative or visit the web site: www.carestreamhealth.com.

CARESTREAM is a trade mark of Carestream Health

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...